Human Milk Oligosaccharides (HMO)
Understanding Human Milk Oligosaccharides (HMOs) Diversity in Human Milk – Ms. Jodi Bettler
Presentation by Ms. Jodi Bettler during the HKDA x WNSC HK Online Symposium 2021 detailing the concept of HMO diversity and how it impacts the health of newborn infants in aspects including overall growth and development, gut and immune health, as well as potential cognitive abilities.
Immune and Microbiome: Nutrients in Focus – Ms. June KC Chan
Lecture by Ms. June KC Chan presented during the HKDA x WNSC HK Online Symposium 2021 discussing the role of nutrition, from breastfeeding to functional oligosaccharides, in gut microbiome and immune maturation during early childhood. [Video was recorded on 30 Apr 2021]
HMOs and Cognitive Development: Updates from the BCP-Enriched Project – Prof. Weili Lin
Presentation by Prof. Weili Lin during the HKDA x WNSC HK Online Symposium 2021, which outlined the latest updates from the Baby-Connectome Project Enriched Study (BCP-Enriched) regarding the significant role of human milk oligosaccharides (HMOs) in early life cognitive development.
Interview with Dr. Sean Austin and Dr. Norbert Sprenger: The diverse profile of human milk oligosaccharides (HMOs) and its significance in early life health outcomes
The formation and characterization of quantifiable HMO structures Tools available for assessing HMO diversity in human milk samples HMO profile influenced by FUT-2 and FUT-3 gene polymorphism Clinical evidence on the role of HMO diversity on early life health
Role of HMOs on Infant Immune Health and Association with Cognition
This infographic summarises the role of human milk oligosaccharides (HMOs) as defense factors and how they can support the developing immune system. In addition, it explores preclinical evidence available that suggests HMOs may play a role in brain developmental processes.
[Literature Library] Human milk oligosaccharides (HMO) profiles of Chinese mothers
This longitudinal study collected single milk samples from 163 mothers and multiple milk samples from 59 mothers in Jiangmen and Guangzhou, China at timepoints from post-partum day 3 until day 168 to analyze their HMO profiles.